Back
AbbVie Stock Price Chart
Sponsored
ABBV
Sponsored
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report
Buy
55
ABBV
AbbVie
Last Price:
181.86
Seasonality Move:
5.3%
7 Day Trial
ALL ACCESS PASS
$
7
S&P Global: Private Equity Invests $36 Billion Into What?
Read More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.
AbbVie Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 178.56 | Buy |
20-day SMA: | 178.98 | Buy |
50-day SMA: | 174.21 | Buy |
200-day SMA: | 153.35 | Buy |
8-day EMA: | 178.99 | Buy |
20-day EMA: | 178.31 | Buy |
50-day EMA: | 173.48 | Buy |
200-day EMA: | 158.85 | Buy |
AbbVie Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.29 | Buy |
Relative Strength Index (14 RSI): | 58.53 | Buy |
Chaikin Money Flow: | 3742329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (177.41 - 180.21) | Buy |
Bollinger Bands (100): | (146.7 - 176.3) | Buy |
AbbVie Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AbbVie Stock
Is AbbVie Stock a Buy?
- AbbVie share price is 180.35 while ABBV 8-day simple moving average is 178.56, which is a Buy signal.
- The stock price of ABBV is 180.35 while AbbVie 20-day SMA is 178.98, which makes it a Buy.
- AbbVie 50-day simple moving average is 174.21 while ABBV share price is 180.35, making it a Buy technically.
- ABBV stock price is 180.35 and AbbVie 200-day simple moving average is 153.35, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
AbbVie Stock Info
Market Cap:
318.58B
Price in USD:
180.35
Share Volume:
5.06M
AbbVie 52-Week Range
52-Week High:
182.89
52-Week Low:
130.96
Buy
55
AbbVie (ABBV)
is a Buy
AbbVie Share Price Forecast
-
What is the AbbVie stock price today?
The AbbVie stock price is 180.35 USD today. -
Will ABBV stock go up or go down?
AbbVie> share price is forecast to RISE/FALL based on technical indicators -
Is AbbVie overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie is not overvalued.
Is AbbVie Stock a Buy?
- AbbVie share price is 180.35 while ABBV 8-day exponential moving average is 178.99, which is a Buy signal.
- The stock price of ABBV is 180.35 while AbbVie 20-day EMA is 178.31, which makes it a Buy.
- AbbVie 50-day exponential moving average is 173.48 while ABBV share price is 180.35, making it a Buy technically.
- ABBV stock price is 180.35 and AbbVie 200-day simple moving average is 158.85, creating a Buy signal.
Fundamental Analysis of AbbVie
Is AbbVie a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.10 per share, and an increase next year of $0.97 per share.
Technical Analysis of AbbVie
Should I short AbbVie stock?
- ABBV Moving Average Covergence Divergence (MACD) indicator is 1.29, suggesting AbbVie is a Buy
- AbbVie Relative Strength Index (RSI) is 58.53, which suggest AbbVie is overbought
- The Bollinger Bands (25) for AbbVie is (177.41 - 180.21), which suggest AbbVie is a Buy
- The Bollinger Bands (100) for AbbVie is (146.7 - 176.3), which suggest AbbVie is a Buy
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.